ID: ALA1774898

Max Phase: Preclinical

Molecular Formula: C23H15F3O4S2

Molecular Weight: 476.50

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CS(=O)(=O)c1cscc1-c1cc(C(=O)O)cc2cc(-c3ccc(C(F)(F)F)cc3)ccc12

Standard InChI:  InChI=1S/C23H15F3O4S2/c1-32(29,30)21-12-31-11-20(21)19-10-16(22(27)28)9-15-8-14(4-7-18(15)19)13-2-5-17(6-3-13)23(24,25)26/h2-12H,1H3,(H,27,28)

Standard InChI Key:  FHMKKRBKVCSGEH-UHFFFAOYSA-N

Associated Targets(non-human)

P2Y purinoceptor 14 107 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 476.50Molecular Weight (Monoisotopic): 476.0364AlogP: 6.36#Rotatable Bonds: 4
Polar Surface Area: 71.44Molecular Species: ACIDHBA: 4HBD: 1
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 3.90CX Basic pKa: CX LogP: 5.41CX LogD: 2.20
Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.37Np Likeness Score: -0.73

References

1. Gauthier JY, Belley M, Deschênes D, Fournier JF, Gagné S, Gareau Y, Hamel M, Hénault M, Hyjazie H, Kargman S, Lavallée G, Levesque JF, Li L, Mamane Y, Mancini J, Morin N, Mulrooney E, Robichaud J, Thérien M, Tranmer G, Wang Z, Wu J, Black WC..  (2011)  The identification of 4,7-disubstituted naphthoic acid derivatives as UDP-competitive antagonists of P2Y14.,  21  (10): [PMID:21507640] [10.1016/j.bmcl.2011.03.081]

Source